scispace - formally typeset
Search or ask a question

What is trientine and copper binding affinity? 


Best insight from top research papers

Trientine, also known as triethylenetetramine (TETA), is a copper-chelating agent used in various medical conditions. It has been studied for its ability to bind copper effectively, promoting copper redistribution and regulating copper levels in the body. Trientine forms stable complexes with copper, which can aid in copper scavenging from tissues and potentially alter copper homeostasis. Studies have shown that trientine treatment can reverse cardiac hypertrophy induced by copper deficiency by replenishing copper levels in the heart. Additionally, trientine has demonstrated potent inhibitory effects on tumor development and angiogenesis by chelating copper, leading to increased apoptosis in tumor cells and endothelial cells.

Answers from top 4 papers

More filters
Papers (4)Insight
Trientine (TETA) is a copper-chelating agent used in Wilson's disease. Its metabolites, MAT and DAT, form stable Cu(II) complexes, with MAT showing high copper binding affinity.
Trientine (TETA) is a copper-selective chelator that delivers copper to the heart, reversing cardiac hypertrophy. The paper does not specify the exact binding affinity of trientine and copper.
Trientine is a copper-chelating agent used in Wilson's disease. It suppresses tumor growth and angiogenesis in hepatocellular carcinoma by binding copper, inhibiting angiogenesis, and promoting apoptosis.
Trientine is a copper chelating tetramine used to deliver copper to ischemic tissue, promoting tissue repair by increasing intracellular copper levels and enhancing copper-dependent activities like HIF-1 transcription.

Related Questions

What are the factors that contribute to selective corrosion on copper wire bonding in electronic devices?5 answersSelective corrosion on copper wire bonding in electronic devices is influenced by various factors. Factors contributing to this corrosion include the presence of moisture, chlorine (Cl), and fluorine (F) which act as catalysts for intermetallic compound (IMC) corrosion. The Cu/Al ratio of the IMC plays a crucial role in determining the corrosion rate, with the most Cu-rich IMC being the most susceptible to corrosion. Additionally, the structural incompatibility between aluminum oxide and copper oxide compromises the passivity of the IMC surface oxide, making it less resistant to corrosion. Process parameters and steps during assembly also play a significant role in either facilitating or preventing corrosion on copper wire bonding. Therefore, controlling these factors through proper design and monitoring is essential to mitigate selective corrosion in semiconductor packages.
What are the types of ligand binding?5 answersLigand binding can occur through different mechanisms. One mechanism is simultaneous binding, where a divalent ligand binds to two identical monovalent molecules to form complexes. Another mechanism is selective binding, where metal ions selectively bind to their receptors at cell membranes. Ligand binding can also involve conformational transitions, with two main descriptions: induced fit and conformational selection. Induced fit assumes that conformational changes occur after the initial binding step to optimize the ligand-target complex, while conformational selection assumes that the free target exists in multiple conformations and the ligand selects the optimal one for binding. Ligand binding can also be influenced by factors such as linkage, where the binding of one ligand is influenced by the binding of another molecule of the same or different ligand, physical variables, or changes in macromolecular assembly state.
Why peptides binding affinity necessary?5 answersPeptides binding affinity is necessary for several reasons. Firstly, identifying tyrosine nitration in proteins, which is involved in many physiological and pathological processes, requires the pre-separation and enrichment of tyrosine-nitrated peptides (TNPs) before mass spectrometry analysis. Secondly, in the treatment of allergic airway diseases, peptide immunotherapy is a promising approach, and the identification of high affinity binding peptides can lead to potential candidates for this therapy. Thirdly, metal-binding peptides play a central role in bionanotechnology, and knowing the sequence modifications that enhance binding affinity is crucial for directing the growth and properties of inorganic nanomaterials. Lastly, understanding the binding affinity of peptides to major histocompatibility complex (MHC-I) is important for developing vaccines and precision medicine, and computational approaches can help in designing peptides with high binding affinity.
What is the Cu metal binding energy value?3 answersThe binding energy value of Cu metal is 7915.867(24) keV.
What kind of copper supplement should I take?3 answers
Which Copper peptide is best?6 answers

See what other people are reading

What makes HNSCC cells form round clusters when cultured on Matrigel?
4 answers
When HNSCC cells are cultured on Matrigel, they form round clusters due to the influence of specific genetic and functional characteristics. Studies have shown that single cell-derived spheroids from HNSCC cell lines exhibit distinct clusters with unique gene expression signatures enriched in pathways like cell cycle, anti-apoptosis, and pro-survival genes associated with EGFR, Wnt, and Notch signaling pathways. Additionally, the formation of spheroids in a 3D culture system can induce the differentiation of cells towards specific phenotypes, as seen in the case of meibomian gland epithelial cells where 3D spheroid culture facilitated meibocyte differentiation. Furthermore, the molecular mechanisms regulating the formation of spheroid cell clusters involve signaling pathways like focal adhesion kinase (FAK) signaling, highlighting the importance of specific protein phosphorylation for spheroid formation.
Why does the morphology of HNSCC cells become round when cultured in Matrigel ?
5 answers
The morphology of head and neck squamous cell carcinoma (HNSCC) cells becomes round when cultured in Matrigel due to the influence of the extracellular matrix on cell behavior. Matrigel facilitates cell migration and shape deformation, leading to a round cell morphology in HNSCC cells. Additionally, the interaction between mesenchymal stroma and HNSCC cells in a 3D spheroid structure promotes the expression of genes associated with epithelial-to-mesenchymal transition (EMT), such as ZEB2 and SNAI2, which can impact cell morphology. The presence of Matrigel in 3D models enhances the formation of well-defined spheroids with uniform morphology, influencing the shape of HNSCC cells towards a rounder phenotype. Therefore, the use of Matrigel in culture systems plays a crucial role in shaping the morphology of HNSCC cells.
How do tumor derived exosomes contribute to the epigenetic changes that occur during prostate cancer progression and metastasis?
5 answers
Tumor-derived exosomes play a crucial role in prostate cancer progression and metastasis by contributing to epigenetic changes. These exosomes carry genetic and molecular cargo, including microRNAs (miRNAs), which can modulate various processes in the tumor microenvironment. Exosome-mediated transfer of miRNAs can regulate cancer cell behavior, such as viability, proliferation, and migration. Additionally, exosomes can influence androgen resistance in prostate cancer cells through specific miRNA interactions. Furthermore, exosomes can transmit mechanical forces from the extracellular matrix, affecting miRNA cargo and promoting cancer cell metastasis. Overall, tumor-derived exosomes act as messengers that facilitate epigenetic regulation, impacting the progression and metastatic potential of prostate cancer cells.
How does the release of exosomes by prostate cancer cells contribute to the development of metastatic disease?
5 answers
The release of exosomes by prostate cancer (PCa) cells plays a crucial role in the development of metastatic disease. Exosomal microRNAs (miRNAs) are key mediators in this process, influencing gene expression changes that promote PCa progression and metastasis. These exosomes loaded with miRNAs facilitate intercellular communication, modulating cell motility, extracellular matrix (ECM) remodeling, and interactions within the tumor microenvironment. Additionally, exosomes contribute to epithelial-mesenchymal transition, angiogenesis, and drug resistance acquisition in PCa, offering potential as diagnostic markers and targeted drug delivery systems. The cargo carried by exosomes reflects the real-time status of cancer cells, making them valuable for diagnosis and prognosis of various cancer types.
How does the RAS gene contribute to the development of preeclampsia?
5 answers
The renin-angiotensin system (RAS) plays a crucial role in the pathogenesis of preeclampsia (PE). Dysregulation of the RAS gene components, such as angiotensin-converting enzyme (ACE) and angiotensin II (Ang II), contributes to the development of PE. Genetic variations in the ACE gene, like the rs4343 polymorphism, have been associated with an increased risk of PE. Additionally, the overactivation of the Ang II/ACE/AT1R axis, along with decreased levels of protective components like ACE 2/Ang 1–7/MasR, can lead to hypertension characteristic of PE. Furthermore, studies suggest that the compensatory alterations in the RAAS during normal pregnancy are disrupted in PE, leading to a disturbance in the delicate equilibrium necessary for maternal and fetal well-being. These findings highlight the intricate involvement of the RAS gene in the pathogenesis of preeclampsia.
How do pro-inflammatory cytokines contribute to angiogenesis of prostate cancer?
4 answers
Pro-inflammatory cytokines play a crucial role in promoting angiogenesis in prostate cancer. These cytokines, such as TNF-α, IL-6, and IL-8, are involved in activating pathways that lead to increased vascularization within the tumor microenvironment. Studies have shown that stimulation of mesenchymal stem cells (MSCs) by pro-inflammatory cytokines like TNF-α and IFN-γ results in the upregulation of pro-angiogenic factors like PDGF and VEGF through the NRF2-HIF-1α pathway, ultimately accelerating prostate cancer growth. Additionally, ER stress in prostate cancer cells induces the transcription of pro-inflammatory cytokines like IL-6 and TNF-α, further contributing to tumor progression and angiogenesis. The interplay between inflammation and angiogenesis in prostate cancer underscores the importance of targeting these pathways for potential therapeutic interventions.
How does GDF15 promote angiogenesis in prostate cancer?
5 answers
Growth Differentiation Factor-15 (GDF15) plays a crucial role in prostate cancer progression by promoting angiogenesis. Research demonstrates that GDF15 interacts with connective tissue growth factor (CCN2) and inhibits CCN2-mediated tube formation in endothelial cells, thereby blocking angiogenesis. Moreover, GDF15 secreted by prostate cancer cells stimulates cancer cell growth and invasion, contributing to tumor progression. Additionally, GDF15 facilitates the growth of prostate cancer in bone by activating osteoclastogenesis through osteoblastic production of CCL2 and RANKL, ultimately promoting bone metastases. These findings highlight the multifaceted role of GDF15 in prostate cancer, where it not only influences cancer cell behavior but also modulates the tumor microenvironment to support angiogenesis and metastasis.
How is IL-6 involved in angiogenesis of prostate cancer?
5 answers
IL-6 plays a crucial role in the angiogenesis of prostate cancer by influencing various pathways. Studies have shown that IL-6 can induce the upregulation of IGF-1Ec and PEc secretion in prostate tumors, leading to the mobilization of mesenchymal stem cells (MSCs) towards the tumor for repair. Additionally, IL-6 can activate the JAK2 and STAT3 pathway through the IL-6 receptor in cancer cells, resulting in the upregulation of IGF-1Ec and PEc secretion, as well as IL-6 expression and secretion. Furthermore, IL-6 has been linked to the promotion of prostate cancer metastasis through the IL-6→AR→TGFβ→MMP-9 signaling pathway, enhancing the invasion ability of prostate cancer cells. These findings highlight the multifaceted role of IL-6 in prostate cancer progression, including its involvement in angiogenesis.
How effective are exosomal miRNAs in the treatment of lung cancer compared to conventional therapies?
5 answers
Exosomal miRNAs show promise in lung cancer treatment compared to conventional therapies. They play crucial roles in tumor growth, metastasis, and drug delivery. Exosomes can serve as diagnostic markers for early lung cancer detectionand carry therapeutic cargoes like drugs and microRNAs. Exosomal miRNAs are involved in regulating cellular processes and tumor immune responses, potentially aiding in differential diagnosis and understanding lung cancer pathophysiology. Moreover, exosomes as drug carriers offer advantages like biocompatibility, low immunogenicity, and the ability to target tumors effectively with reduced toxicity. While exosomal miRNAs hold promise for improving lung cancer treatment outcomes, further research and clinical testing are needed to fully establish their efficacy.
What are the drug resistant mechanism of glioblastoma?
5 answers
Glioblastoma (GBM) exhibits drug resistance mechanisms that hinder effective treatment. Resistance to temozolomide (TMZ), a common chemotherapy for GBM, arises from various factors. These include DNA repair processes, cellular autophagy, glioma stem cells, and the tumor microenvironment. Additionally, the development of multidrug resistance in GBM involves the selection of resistant tumor clones during therapy, leading to tumor growth and angiogenesis, which supports metastasis and recurrence. Furthermore, platinum drugs like cisplatin face resistance in gliomas due to factors such as decreased drug concentration, enhanced DNA repair, and altered apoptosis pathways. Understanding these resistance mechanisms at the molecular level is crucial for developing effective treatment strategies for combating drug resistance in glioblastoma.
What is an integrin inhibitor?
5 answers
An integrin inhibitor is a type of compound that targets integrin receptors, which play crucial roles in cell-matrix and cell-cell interactions. Integrins are involved in various cellular activities like migration, survival, and growth, making them significant in cancer progression and fibrotic diseases. Cilengitide, a cyclic RGD pentapeptide, is an example of an integrin inhibitor that targets specific integrins like αvβ3, αvβ5, and α5β1. Studies have shown that integrin inhibitors like cilengitide can impact cell adhesion, migration, proliferation, and invasion. These inhibitors have been explored for their potential in cancer treatment, particularly in meningiomas, where they have shown antimigratory properties and potential radiosensitization effects.